
Sign up to save your podcasts
Or


A conversation with Dr. Ira Casson (who served on the National Football League’s committee on mild traumatic brain injury and co-authored several of its studies on MTBI) reveals that it may be impossible to assess the value of its six-season study. Despite the author’s defense of the methods used to conduct the research, there’s room for skepticism, both in the light of a New York Times story reporting that over 10% of such injuries may have gone unreported and the study’s assumption that all teams reported all injuries.
We asked the League to make the studies’ first author available for this conversation, and they declined.
By NEJM Group4.5
5656 ratings
A conversation with Dr. Ira Casson (who served on the National Football League’s committee on mild traumatic brain injury and co-authored several of its studies on MTBI) reveals that it may be impossible to assess the value of its six-season study. Despite the author’s defense of the methods used to conduct the research, there’s room for skepticism, both in the light of a New York Times story reporting that over 10% of such injuries may have gone unreported and the study’s assumption that all teams reported all injuries.
We asked the League to make the studies’ first author available for this conversation, and they declined.

7,594 Listeners

319 Listeners

2,058 Listeners

126 Listeners

496 Listeners

293 Listeners

885 Listeners

263 Listeners

3,343 Listeners

112,027 Listeners

90 Listeners

5 Listeners

92 Listeners

513 Listeners

2,550 Listeners

369 Listeners

15,836 Listeners

61 Listeners

31 Listeners

66 Listeners